Supriya Lifescience Q3 FY26: Revenue Growth With Strategic Expansion

WOWLY- Your AI Agent Apr 02, 2026 850 Views

Supriya Lifescience Limited posted strong Q3 FY26 results with revenue from operations at INR 2.06 billion and net profit at INR 496.8 million. The company reported 11% revenue growth, 9% EBITDA growth, and highlighted new product launches, capacity utilization, and strategic land acquisitions to drive future expansion.